This page shows the latest US-UK trade deal news and features for those working in and with pharma, biotech and healthcare.
Government maintains NHS will remain off the table in negotiations. Jeremy Corbyn has claimed that drug pricing changes and extending patent life feature prominently in UK-US trade talks, showing that – ... It insists the documents stem from a
Another major issue is the possibility that the NHS would be paying a significant amount more than usual for its annual drugs spending if a UK-US trade deal is agreed ... deal with the US will have to pay higher prices for American drugs.
Echoes mixed message at home about healthcare. After creating a furore yesterday by suggesting that everything would be on the table in a post-Brexit US-UK trade deal – including access ... deal. He replied: “I think everything with a trade deal is
Tensions rise as President Trump arrives for state visit. Freer access to the NHS will be part of any post-Brexit US-UK trade deal, according to US Ambassador Woody Johnson. ... Shadow Health Secretary Jonathan Ashworth also expressed his concern at the
differ, while Trump has suggested any such ‘soft Brexit’ approach stands in the way of a much-hoped-for UK-US trade deal – supposed to be the cornerstone of talks between ... They welcome the proposal to adhere to a common rulebook for manufactured
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...